Organogenesis Holdings Inc Cash Flow Quality Index
Organogenesis Holdings Inc cash flow quality index. Organogenesis Holdings Inc (ORGO) has a Cash Flow Quality Index of 0.14x as of September 2025. Operating cash flow of $3.08 Million is below net income of $21.57 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Organogenesis Holdings Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Organogenesis Holdings Inc (2020–2024)
Cash flow quality index of Organogenesis Holdings Inc from 2020 to 2024. Historical Cash Flow Quality Index for Organogenesis Holdings Inc across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Organogenesis Holdings Inc (ORGO) net asset quality to measure how much of total assets are equity-financed.
Organogenesis Holdings Inc Cash Flow Quality Index by Year (2020–2024)
Organogenesis Holdings Inc cash flow quality index by year from 2020 to 2024. Year-by-year earnings quality comparison for Organogenesis Holdings Inc. For the full cash flow conversion analysis, see Organogenesis Holdings Inc operating cash flow efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 16.50x | $14.21 Million | $861.00K | ▲ +163.9% |
| 2023 | 6.25x | $30.92 Million | $4.95 Million | ▲ +290.6% |
| 2022 | 1.60x | $24.86 Million | $15.53 Million | ▲ +145.1% |
| 2021 | 0.65x | $61.98 Million | $94.90 Million | ▲ +105.9% |
| 2020 | 0.32x | $5.47 Million | $17.23 Million | — |